Back
BridgeBio Pharma Stock Price Chart
Sponsored
BBIO
Sponsored
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surge
Sell
37
BBIO
BridgeBio Pharma
Last Price:
27.03
Seasonality Move:
32.95%
7 Day Trial
ALL ACCESS PASS
$
7
NOW is the time to get in on this trillion-dollar megatrend
Get it here.- The current trend is relatively stagnant and BBIO is experiencing slight buying pressure.
BridgeBio Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.07 | Buy |
20-day SMA: | 26.31 | Sell |
50-day SMA: | 29.08 | Sell |
200-day SMA: | 30.87 | Sell |
8-day EMA: | 25.32 | Buy |
20-day EMA: | 26.27 | Sell |
50-day EMA: | 28.62 | Sell |
200-day EMA: | 28.56 | Sell |
BridgeBio Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.23 | Sell |
Relative Strength Index (14 RSI): | 41.18 | Sell |
Chaikin Money Flow: | 234223 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25 - 29.14) | Sell |
Bollinger Bands (100): | (28.04 - 37.96) | Sell |
BridgeBio Pharma Technical Analysis
Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BridgeBio Pharma Stock
Is BridgeBio Pharma Stock a Buy?
- BridgeBio Pharma share price is 25.61 while BBIO 8-day simple moving average is 25.07, which is a Buy signal.
- The stock price of BBIO is 25.61 while BridgeBio Pharma 20-day SMA is 26.31, which makes it a Sell.
- BridgeBio Pharma 50-day simple moving average is 29.08 while BBIO share price is 25.61, making it a Sell technically.
- BBIO stock price is 25.61 and BridgeBio Pharma 200-day simple moving average is 30.87, creating a Sell signal.
BBIO Technical Analysis vs Fundamental Analysis
Sell
37
BridgeBio Pharma (BBIO)
is a Sell
Is BridgeBio Pharma a Buy or a Sell?
-
BridgeBio Pharma stock is rated a Sell
The current BridgeBio Pharma [BBIO] share price is $25.61. The Score for BBIO is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
BridgeBio Pharma Stock Info
Market Cap:
4.5B
Price in USD:
25.61
Share Volume:
1.17M
BridgeBio Pharma 52-Week Range
52-Week High:
44.32
52-Week Low:
12.75
Sell
37
BridgeBio Pharma (BBIO)
is a Sell
BridgeBio Pharma Share Price Forecast
-
What is the BridgeBio Pharma stock price today?
The BridgeBio Pharma stock price is 25.61 USD today. -
Will BBIO stock go up or go down?
BridgeBio Pharma> share price is forecast to RISE/FALL based on technical indicators -
Is BridgeBio Pharma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, BridgeBio Pharma is overvalued.
Is BridgeBio Pharma Stock a Buy?
- BridgeBio Pharma share price is 25.61 while BBIO 8-day exponential moving average is 25.32, which is a Buy signal.
- The stock price of BBIO is 25.61 while BridgeBio Pharma 20-day EMA is 26.27, which makes it a Sell.
- BridgeBio Pharma 50-day exponential moving average is 28.62 while BBIO share price is 25.61, making it a Sell technically.
- BBIO stock price is 25.61 and BridgeBio Pharma 200-day simple moving average is 28.56, creating a Sell signal.
Fundamental Analysis of BridgeBio Pharma
Is BridgeBio Pharma a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.16 per share, an increase this year of $0.46 per share, and an increase next year of $0.54 per share.
Technical Analysis of BridgeBio Pharma
Should I short BridgeBio Pharma stock?
- BBIO Moving Average Covergence Divergence (MACD) indicator is -1.23, suggesting BridgeBio Pharma is a Sell
- BridgeBio Pharma Relative Strength Index (RSI) is 41.18, which suggest BridgeBio Pharma is oversold
- The Bollinger Bands (25) for BridgeBio Pharma is (25 - 29.14), which suggest BridgeBio Pharma is a Sell
- The Bollinger Bands (100) for BridgeBio Pharma is (28.04 - 37.96), which suggest BridgeBio Pharma is a Sell
* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.